Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

J&J CEO Gorsky spurns U.S. congressional hearing on carcinogens in talc products

Published 2019-12-09, 04:36 p/m
Updated 2019-12-09, 04:41 p/m
J&J CEO Gorsky spurns U.S. congressional hearing on carcinogens in talc products

By Lisa Girion and Carl O'Donnell

(Reuters) - Johnson & Johnson Chief Executive Officer Alex Gorsky has declined to appear at a U.S. congressional hearing set for Tuesday on the safety of the company's Baby Powder and other talc-based cosmetics.

In a hearing announcement, the House of Representatives Subcommittee on Economic and Consumer Policy said that its efforts to persuade Gorsky to testify included "repeated attempts to accommodate the company" over nearly a month.

But J&J spokesman Ernie Knewitz said that the subcommittee rejected the company's offers to send a talc testing expert or a J&J executive in charge of consumer products. The panel will hear from experts on the health ramifications of talc powders and cosmetics, and on methods for detecting cancer-causing asbestos in such products.

Gorsky "is not, as we have repeatedly told the Subcommittee, an expert in the stated subject of the hearing," Knewitz said.

"We have respectfully declined the invitation for our CEO to testify," Knewitz said.

Gorsky has played a lead role in J&J’s efforts to reassure consumers and investors that its talc powders are safe and asbestos free. It was Gorsky who issued a statement vouching for the safety of the products last year after a jury issued a $4.69 billion verdict for 22 women who sued over allegations their ovarian cancers were caused by J&J powders.

Gorsky appeared on CNBC’s "Mad Money with Jim Cramer" and in a video posted on J&J’s website to rebut a December 2018 Reuters report https://www.reuters.com/investigates/special-report/johnsonandjohnson-cancer that the company knew for decades about the presence of small amounts of asbestos in its talc and powders.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"Since tests for asbestos in talc were first developed, J&J’s Baby Powder has never contained asbestos," Gorsky said in the video. 

In October, Gorsky testified in a deposition https://www.reuters.com/article/us-johnson-johnson-talc-ceo-insight/johnson-johnson-ceo-testified-baby-powder-was-safe-13-days-before-fda-bombshell-idUSKBN1X12GF in a lawsuit filed by an Indiana man, saying, "We unequivocally believe that our talc and our baby powder does not contain asbestos." J&J faces more than 16,000 similar lawsuits.

Concerns over asbestos in talc cosmetics have grown in recent months as the U.S. Food and Drug Administration announced that the carcinogen had been found in several products, including a bottle of Baby Powder.

J&J said it recalled 33,000 bottles of Baby Powder "out of an abundance of caution." Later, J&J said labs it hired found no asbestos - other than some contamination it blamed on an air conditioner - in samples from the same Baby Powder bottle and its production lot.

The FDA has said it stands by its finding.

Chief executives of companies embroiled in controversies routinely comply with lawmakers’ invitations to testify.

In recent months, the chief executives of Boeing (NYSE:BA) and Facebook (NASDAQ:FB) have appeared before congressional committees to answer questions about how their companies were safeguarding consumers.

Charles M. Elson, director of the John L. Weinberg Center for Corporate Governance at the University of Delaware, said CEOs have a responsibility to go to Washington when Congress calls, just like other citizens.

But Elson said Gorsky's pass was understandable. He said the chief executive and his advisers probably figured that the downside was greater to testifying than not.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"It's being invited in for a punch in the nose," Elson said. For Gorsky, "nothing good will come out of it."

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.